Page 1 of Clinical Trials for Drug Sorafenib, 522 Total Matches
- 1CompletedLast Updated: January 19, 2012Condition(s): Pancreatic Neoplasms; Bile Duct Neoplasms
- 2RecruitingLast Updated: May 19, 2012Condition(s): Hepatocellular Carcinoma; Hepatocellular Cancer; Carcinoma, Hepatocellular
- 3TerminatedLast Updated: December 3, 2010Condition(s): Prostate Cancer
- 4RecruitingLast Updated: March 19, 2012Condition(s): Solid Tumors; Advanced Cancer
- 5SuspendedLast Updated: October 20, 2010Condition(s): Advanced Solid Tumors
- 6CompletedLast Updated: January 27, 2010Condition(s): Advanced Solid Tumor
- 7CompletedLast Updated: April 10, 2012Condition(s): Carcinoma, Renal Cell
- 8CompletedLast Updated: April 10, 2012Condition(s): Carcinoma, Renal Cell
- 9RecruitingLast Updated: May 9, 2012Condition(s): Advanced Cancer
- 10Active, not recruitingLast Updated: December 5, 2011Condition(s): SOLID TUMORS
- 11RecruitingLast Updated: May 6, 2012Condition(s): Carcinoma, Hepatocellular
- 12Active, not recruitingLast Updated: January 3, 2012Condition(s): Kidney Cancer
- 13RecruitingLast Updated: May 22, 2012Condition(s): Solid Tumors
- 14RecruitingLast Updated: April 5, 2012Condition(s): Hepatocellular Carcinoma
- 15RecruitingLast Updated: February 13, 2009Condition(s): Hepatocellular Carcinoma
- 16RecruitingLast Updated: April 4, 2012Condition(s): Hepatocellular Carcinoma
- 17Not yet recruitingLast Updated: April 24, 2012Condition(s): PHENYTOIN/SORAFENIB [VA Drug Interaction]; Liver Neoplasms; Carcinoma, Hepatocellular; Digestive System Neoplasms; Neoplasms by Site; Liver Diseases; Adenocarcinoma; Carcinoma; Neoplasms, Glandular and Epithelial; Neoplasms by Histologic Type; DOXORUBICIN/TRASTUZUMAB [VA Drug Interaction]; HBV
- 18TerminatedLast Updated: August 3, 2010Condition(s): Liver Carcinoma
- 19RecruitingLast Updated: April 18, 2012Condition(s): Hepatocellular Carcinoma
- 20Active, not recruitingLast Updated: May 15, 2012Condition(s): Renal Cell Carcinoma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Sorafenib
